IBDEI0RU ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13056,1,4,0)
 ;;=4^R09.81
 ;;^UTILITY(U,$J,358.3,13056,2)
 ;;=^5019203
 ;;^UTILITY(U,$J,358.3,13057,0)
 ;;=I69.928^^53^584^22
 ;;^UTILITY(U,$J,358.3,13057,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13057,1,3,0)
 ;;=3^Speech/Lang Deficit Following Cerebvasc Disease
 ;;^UTILITY(U,$J,358.3,13057,1,4,0)
 ;;=4^I69.928
 ;;^UTILITY(U,$J,358.3,13057,2)
 ;;=^5007557
 ;;^UTILITY(U,$J,358.3,13058,0)
 ;;=I69.328^^53^584^23
 ;;^UTILITY(U,$J,358.3,13058,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13058,1,3,0)
 ;;=3^Speech/Lang Deficit Following Cerebvasc Infarc
 ;;^UTILITY(U,$J,358.3,13058,1,4,0)
 ;;=4^I69.328
 ;;^UTILITY(U,$J,358.3,13058,2)
 ;;=^5007495
 ;;^UTILITY(U,$J,358.3,13059,0)
 ;;=E04.0^^53^585^39
 ;;^UTILITY(U,$J,358.3,13059,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13059,1,3,0)
 ;;=3^Nontoxic Diffuse Goiter
 ;;^UTILITY(U,$J,358.3,13059,1,4,0)
 ;;=4^E04.0
 ;;^UTILITY(U,$J,358.3,13059,2)
 ;;=^5002477
 ;;^UTILITY(U,$J,358.3,13060,0)
 ;;=E04.1^^53^585^41
 ;;^UTILITY(U,$J,358.3,13060,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13060,1,3,0)
 ;;=3^Nontoxic Single Thyroid Nodule
 ;;^UTILITY(U,$J,358.3,13060,1,4,0)
 ;;=4^E04.1
 ;;^UTILITY(U,$J,358.3,13060,2)
 ;;=^5002478
 ;;^UTILITY(U,$J,358.3,13061,0)
 ;;=E04.2^^53^585^40
 ;;^UTILITY(U,$J,358.3,13061,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13061,1,3,0)
 ;;=3^Nontoxic Multinodular Goiter
 ;;^UTILITY(U,$J,358.3,13061,1,4,0)
 ;;=4^E04.2
 ;;^UTILITY(U,$J,358.3,13061,2)
 ;;=^267790
 ;;^UTILITY(U,$J,358.3,13062,0)
 ;;=E01.1^^53^585^36
 ;;^UTILITY(U,$J,358.3,13062,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13062,1,3,0)
 ;;=3^Iodine-Deficiency Related Multinodular (Endemic) Goiter
 ;;^UTILITY(U,$J,358.3,13062,1,4,0)
 ;;=4^E01.1
 ;;^UTILITY(U,$J,358.3,13062,2)
 ;;=^5002465
 ;;^UTILITY(U,$J,358.3,13063,0)
 ;;=E05.00^^53^585^56
 ;;^UTILITY(U,$J,358.3,13063,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13063,1,3,0)
 ;;=3^Thyrotoxicosis w/ Diffuse Goiter w/o Thyrotoxic Crisis
 ;;^UTILITY(U,$J,358.3,13063,1,4,0)
 ;;=4^E05.00
 ;;^UTILITY(U,$J,358.3,13063,2)
 ;;=^5002481
 ;;^UTILITY(U,$J,358.3,13064,0)
 ;;=E05.01^^53^585^55
 ;;^UTILITY(U,$J,358.3,13064,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13064,1,3,0)
 ;;=3^Thyrotoxicosis w/ Diffuse Goiter w/ Thyrotoxic Crisis/Storm
 ;;^UTILITY(U,$J,358.3,13064,1,4,0)
 ;;=4^E05.01
 ;;^UTILITY(U,$J,358.3,13064,2)
 ;;=^5002482
 ;;^UTILITY(U,$J,358.3,13065,0)
 ;;=E05.90^^53^585^58
 ;;^UTILITY(U,$J,358.3,13065,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13065,1,3,0)
 ;;=3^Thyrotoxicosis,Unspec w/o Thyrotoxic Crisis/Storm
 ;;^UTILITY(U,$J,358.3,13065,1,4,0)
 ;;=4^E05.90
 ;;^UTILITY(U,$J,358.3,13065,2)
 ;;=^5002492
 ;;^UTILITY(U,$J,358.3,13066,0)
 ;;=E05.91^^53^585^57
 ;;^UTILITY(U,$J,358.3,13066,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13066,1,3,0)
 ;;=3^Thyrotoxicosis,Unspec w/ Thyrotoxic Crisis/Storm
 ;;^UTILITY(U,$J,358.3,13066,1,4,0)
 ;;=4^E05.91
 ;;^UTILITY(U,$J,358.3,13066,2)
 ;;=^5002493
 ;;^UTILITY(U,$J,358.3,13067,0)
 ;;=E89.0^^53^585^50
 ;;^UTILITY(U,$J,358.3,13067,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13067,1,3,0)
 ;;=3^Postprocedural Hypothyroidism
 ;;^UTILITY(U,$J,358.3,13067,1,4,0)
 ;;=4^E89.0
 ;;^UTILITY(U,$J,358.3,13067,2)
 ;;=^5003035
 ;;^UTILITY(U,$J,358.3,13068,0)
 ;;=E03.2^^53^585^32
 ;;^UTILITY(U,$J,358.3,13068,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13068,1,3,0)
 ;;=3^Hypothyroidism d/t Meds/Oth Exogenous Substances
 ;;^UTILITY(U,$J,358.3,13068,1,4,0)
 ;;=4^E03.2
 ;;^UTILITY(U,$J,358.3,13068,2)
 ;;=^5002471
 ;;^UTILITY(U,$J,358.3,13069,0)
 ;;=E03.9^^53^585^33
